Latest revenue
$773.6K
as of 2026-03-31
Latest net income
$-2.3M
as of 2026-03-31
Net margin
-298.5%
as of 2026-03-31
Community sentiment
Where do you think LUCY is heading?
Keep private notes on LUCY — thesis, target price, catalysts to watch.
Visible only to you. Never shared. Never used to train AI.
LUCY vs S&P 500 · rebased to 100
Live market
delayed ≤15 min- Market cap
- $5.8M
- Enterprise value
- $1.4M
- P/E (trailing)
- —
- Forward P/E
- —
- P/B
- 0.69×
- Dividend yield
- 0.0%
- 52-wk high
- $4.97
- 52-wk low
- $0.89
- Beta
- —
- Shares out
- 6.4M
What this company does
Item 1. Business. Our History We develop and sell cutting-edge smart eyewear – including prescription eyeglasses, ready-to-wear sunglasses, safety glasses, and sport glasses – that is designed to allow our customers to remain connected to their digital lives. Founded and headquartered in Miami, Florida, we were initially organized as a Florida limited liability company effective August 15, 2019. On March 26, 2020, we converted from a Florida limited liability company into a Florida corporation. We were founded by Lucyd Ltd., the inventor of the technology that our products are based upon, which is a portfolio company of Tekcapital Europe Ltd. (“Tekcapital”). Tekcapital is a U.K. based…
AI summary unavailable — showing raw filing excerpt
Generated from LUCY's filing dated 2026-03-25
Key risks
Item 1A. Risk Factors. Our business involves a high degree of risk and uncertainty, including the following. Summary Risk Factors The risk factors described below are a summary of the principal risk factors associated with an investment in us. These are not the only risks we face. You should carefully consider these risk factors, together with the risk factors set forth in detail below and the other reports and documents filed by us with the SEC. Risks Related to our Business, Strategy and Industry ● Our failure to meet the continued listing requirements of Nasdaq could result in a delisting of our securities. ● The optical industry is highly competitive, and if we do not compete…
AI summary unavailable — showing raw filing excerpt
Generated from LUCY's filing dated 2026-03-25
ActaClear Score
Computed from 5 years of SEC fundamentals + latest market data, ranked within Ophthalmic Goods (7 peers). 10 = best in industry, 5 = median, 0 = worst. Refreshed Jun 10, 2026.